Use of L-arginine optionally combined with magnesium for the treatment of sickle cell disease and/or pulmonary hypertension

摘要

The invention features methods and compositions for treatment of conditions associated with decreased nitric oxide bioavailability, such as a condition associated with elevated arginase activity, using an arginine-based therapy, including combination therapy with an arginase inhibitor and/or magnesium